Edinburgh Research Explorer

Prof David Newby

BHF Duke of Edinburgh Chair of Cardiology

  1. 1995
  2. Enalapril overdose and the corrective effect of intravenous angiotensin II

    Newby, D. E., Lee, M. R., Gray, A. J. & Boon, N. A., Jul 1995, In : British Journal of Clinical Pharmacology. 40, 1, p. 103-4 2 p.

    Research output: Contribution to journalArticle

  3. 1996
  4. Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats

    Newby, D. E., Neilson, J. M., Jarvie, D. R. & Boon, N. A., Oct 1996, In : Heart. 76, 4, p. 355-7 3 p.

    Research output: Contribution to journalArticle

  5. Advances in clinical pharmacology and therapeutics: endothelin

    Newby, D. E. & Webb, D. J., 2 Oct 1996, In : British journal of hospital medicine. 56, 7, p. 360-4 5 p.

    Research output: Contribution to journalArticle

  6. 1997
  7. Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide

    Newby, D. E., Boon, N. A. & Webb, D. J., Feb 1997, In : Clinical science. 92, 2, p. 133-8 6 p.

    Research output: Contribution to journalArticle

  8. The endothelin system in cardiovascular disease

    Newby, D. E. & Webb, D. J., 22 Feb 1997, In : BMJ. 314, 7080, p. 531-2 2 p.

    Research output: Contribution to journalArticle

  9. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability

    Newby, D. E., Sciberras, D. G., Mendel, C. M., Gertz, B. J., Boon, N. A. & Webb, D. J., May 1997, In : British Journal of Clinical Pharmacology. 43, 5, p. 493-9 7 p.

    Research output: Contribution to journalArticle

  10. Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans

    Masumori, S., Newby, D. E., Strachan, F. E., Boon, N. A. & Webb, D. J., Sep 1997, In : Clinical pharmacology and therapeutics. 62, 3, p. 327-33 7 p.

    Research output: Contribution to journalArticle

  11. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction

    Ferro, C. J., Haynes, W. G., Johnston, N. R., Lomax, C. C., Newby, D. E. & Webb, D. J., Oct 1997, In : British Journal of Clinical Pharmacology. 44, 4, p. 377-83 7 p.

    Research output: Contribution to journalArticle

  12. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man

    Newby, D. E., Masumori, S., Johnston, N. R., Boon, N. A. & Webb, D. J., Nov 1997, In : Cardiovascular Research. 36, 2, p. 268-75 8 p.

    Research output: Contribution to journalArticle

  13. 1998
  14. Regulation of peripheral vascular tone in patients with heart failure: Contribution of angiotensin II

    Newby, D. E., Webb, D. J., Flapan, A. D., Boon, N. A., Fox, K. A. A. & Goodfield, N. E. R., 1 Jan 1998, In : Heart. 80, 2, p. 134-141 8 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...67 Next